AUTOIMMUNE DISEASE
Clinical trials for AUTOIMMUNE DISEASE explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE DISEASE trials appear
Sign up with your email to follow new studies for AUTOIMMUNE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to calm immune attack on kidneys
Disease control Recruiting nowThis study tests whether combining two immune-suppressing drugs, rituximab and cyclosporine, can safely reduce protein leakage in the urine of people with membranous nephropathy, a kidney disease where the immune system damages kidney filters. About 30 adults with persistent prot…
Matched conditions: AUTOIMMUNE DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for vulnerable patients: remdesivir trial targets RSV in Immune-Weakened individuals
Disease control Recruiting nowThis study tests if the antiviral drug remdesivir can safely treat RSV (a common respiratory virus) in 60 adults whose immune systems are weakened by certain cancer or autoimmune treatments. Participants must have a confirmed RSV infection with symptoms. The main goal is to see i…
Matched conditions: AUTOIMMUNE DISEASE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope: immune drug tested in patients with both autoimmune disease and cancer
Disease control Recruiting nowThis study is for people who have both an autoimmune disorder (like rheumatoid arthritis, lupus, or multiple sclerosis) and advanced cancer that has spread or cannot be removed. It tests a drug called nivolumab, which helps the immune system fight cancer, given alone or with othe…
Matched conditions: AUTOIMMUNE DISEASE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
New autoimmune drug candidate GenSci136 enters first human safety trial
Knowledge-focused Recruiting nowThis early-stage study is testing a single injection of a new drug called GenSci136 in 48 healthy adults in China. The main goal is to check if the drug is safe and how the body processes it. This information will help guide future studies in people with autoimmune diseases.
Matched conditions: AUTOIMMUNE DISEASE
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 07:08 UTC
-
New tool aims to help melanoma patients with autoimmune conditions navigate treatment choices
Knowledge-focused Recruiting nowThis study is testing a new educational tool designed for people with melanoma who also have an autoimmune disease (like rheumatoid arthritis or Crohn's disease). The tool helps patients understand immune checkpoint inhibitor drugs and their possible side effects. Researchers wil…
Matched conditions: AUTOIMMUNE DISEASE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 06:59 UTC
-
Scientists track lung disease to uncover hidden causes
Knowledge-focused Recruiting nowThis study follows 900 people with bronchiectasis (damaged and infected airways) to learn why they get repeated lung infections. Researchers will collect blood, spit, and genetic samples from patients and their family members. No new treatments are tested; the goal is to find inh…
Matched conditions: AUTOIMMUNE DISEASE
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
DNA testing for better drug choices: a 1200-Patient study
Knowledge-focused Recruiting nowThis study collects DNA samples from 1200 adults receiving routine care at the University of Chicago. Researchers test for genetic differences that could affect how patients respond to certain medications, including risk of side effects. The results are shared with their doctors,…
Matched conditions: AUTOIMMUNE DISEASE
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC